Last 26 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.41 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 6.14 | 7.38 | 8.69 | 6.45 | 7.70 | 7.90 | 6.06 | 8.95 | 7.64 | 8.83 | 10.01 | 7.44 | 8.49 | 16.98 | 15.13 | 23.59 | 30.60 | 38.54 | 71.33 | 115.78 | 246.03 |
| — | -6.6% | +43.5% | -27.9% | +0.7% | -10.5% | -39.5% | +20.2% | -9.9% | -48.0% | -33.9% | -68.4% | -72.3% | -55.9% | -78.8% | -79.6% | -87.6% | -89.7% | — | -88.4% | — | |
| P/B Ratio | 0.40 | 0.41 | 0.39 | 0.41 | 0.45 | 0.43 | 0.32 | 0.43 | 0.35 | 0.30 | 0.32 | 0.31 | 0.35 | 0.65 | 0.57 | 0.81 | 1.06 | 1.18 | 1.94 | 2.79 | 4.10 |
| — | -5.9% | +20.7% | -6.0% | +28.6% | +44.9% | +0.9% | +37.6% | +0.4% | -54.3% | -43.5% | -61.5% | -67.1% | -44.9% | -70.8% | -70.8% | -74.2% | -68.8% | -65.3% | -10.2% | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 49.7% | 48.5% | 33.1% | 50.5% | 49.3% | 50.7% | 48.3% | 9.3% | 46.9% | 7.5% | -4.3% | 41.7% | 15.8% | 23.0% | 18.8% | 40.2% | 22.3% | 19.6% | 11.1% | -14.6% | 22.3% |
| — | -4.2% | -31.5% | +444.4% | +5.2% | +579.6% | +1212.9% | -77.8% | +196.5% | -67.6% | -123.1% | +3.8% | -29.1% | +17.8% | +68.7% | +375.6% | -0.1% | +38.7% | — | +64.5% | — | |
| Operating Margin | -483.9% | -542.9% | -637.7% | -426.8% | -487.4% | -522.1% | -500.1% | -596.1% | -617.1% | -882.0% | -821.7% | -531.9% | -621.0% | -697.1% | -677.2% | -646.2% | -633.8% | -647.2% | -718.2% | -656.6% | -859.7% |
| — | -4.0% | -27.5% | +28.4% | +21.0% | +40.8% | +39.1% | -12.1% | +0.6% | -26.5% | -21.3% | +17.7% | +2.0% | -7.7% | +5.7% | +1.6% | +26.3% | +48.2% | — | +83.1% | — | |
| Net Margin | -456.6% | -544.8% | -622.2% | -392.7% | -459.4% | -494.0% | -481.3% | -550.6% | -541.0% | -743.8% | -674.5% | -425.8% | -506.7% | -584.6% | -591.1% | -583.4% | -606.3% | -630.1% | -713.9% | -651.0% | -857.1% |
| — | -10.3% | -29.3% | +28.7% | +15.1% | +33.6% | +28.6% | -29.3% | -6.8% | -27.2% | -14.1% | +27.0% | +16.4% | +7.2% | +17.2% | +10.4% | +29.3% | +49.4% | — | +83.1% | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -25.1% | -7.2% | -6.7% | -6.0% | -6.5% | -6.5% | -6.2% | -6.5% | -6.0% | -6.1% | -5.3% | -4.4% | -5.1% | -5.5% | -5.4% | -5.0% | -5.2% | -4.8% | -4.8% | -3.9% | -3.5% |
| — | -11.6% | -7.6% | +6.9% | -8.3% | -6.1% | -17.9% | -45.8% | -17.4% | -10.9% | +2.7% | +10.9% | +0.7% | -15.7% | -13.9% | -28.4% | -46.1% | -52.1% | -40.7% | +16.5% | +54.3% | |
| ROA | -22.2% | -6.4% | -5.9% | -5.3% | -5.8% | -5.8% | -5.6% | -5.8% | -5.4% | -5.5% | -4.8% | -4.0% | -4.7% | -5.0% | -5.0% | -4.6% | -4.7% | -4.4% | -4.4% | -3.7% | -3.5% |
| — | -10.2% | -6.0% | +8.8% | -7.0% | -5.2% | -16.0% | -43.5% | -16.0% | -9.9% | +3.4% | +11.4% | +1.3% | -14.7% | -12.4% | -23.2% | -36.6% | -42.5% | -33.4% | +17.6% | +43.8% | |
| ROIC | -21.3% | -5.8% | -5.7% | -5.4% | -5.5% | -5.5% | -5.2% | -5.5% | -5.3% | -5.7% | -5.0% | -4.2% | -4.9% | -5.2% | -4.9% | -4.4% | -4.5% | -4.9% | -6.1% | -6.3% | -8.2% |
| — | -4.4% | -9.7% | +1.9% | -4.8% | +2.9% | -3.4% | -29.5% | -7.1% | -9.0% | -2.6% | +5.0% | -10.1% | -5.7% | +19.5% | +29.1% | +45.3% | +51.7% | +53.6% | +34.1% | -81.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.09 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | — |
| — | +15.2% | +16.7% | +15.1% | +16.1% | +15.9% | +13.2% | +11.3% | +8.2% | +5.9% | +4.6% | +6.5% | +9.0% | +10.3% | +11.0% | +44.1% | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 12.84 | 14.74 | 17.73 | 12.84 | 14.25 | 19.15 | 19.34 | 16.53 | 18.36 | 17.59 | 25.27 | 25.00 | 27.65 | 21.22 | 31.26 | 34.57 | 33.08 | 31.07 | 41.02 | 30.67 | 53.83 |
| — | -23.0% | -8.4% | -22.3% | -22.4% | +8.8% | -23.4% | -33.9% | -33.6% | -17.1% | -19.2% | -27.7% | -16.4% | -31.7% | -23.8% | +12.7% | -38.5% | -50.6% | -43.4% | -42.7% | +156.4% | |
| Quick Ratio | 12.35 | 14.06 | 16.94 | 12.35 | 13.71 | 18.51 | 18.81 | 16.04 | 17.88 | 17.15 | 24.81 | 24.66 | 27.31 | 20.89 | 30.94 | 34.20 | 32.65 | 30.61 | 40.70 | 30.36 | 53.57 |
| — | -24.0% | -9.9% | -23.0% | -23.3% | +8.0% | -24.2% | -34.9% | -34.5% | -17.9% | -19.8% | -27.9% | -16.3% | -31.8% | -24.0% | +12.6% | -39.0% | -51.1% | -43.7% | -43.2% | +155.1% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -897.23 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 26 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SEER stock.
Seer, Inc.'s current P/E is -1.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Seer, Inc.'s current operating margin is -483.9%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Seer, Inc.'s business trajectory between earnings reports.